[1]
Arber, C., Baerlocher, G., Chalandon, Y., Daskalakis, M., Duchosal, M., Fehr, M., Gerull, S., Güngör, T., Nair, G., Pabst, T., Passweg, J.R., Piccolruaz, B., Renner, C., Ruefer, A., Schneidawind, D., Stüssi, G., Zeerleder, S. and Halter, J.P. 2024. Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data. Swiss Medical Weekly. 154, 10 (Oct. 2024), 3704. DOI:https://doi.org/10.57187/s.3704.